|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance 显示文摘 | Buysschaert M Dramais AS Wallemacq PE | 2000 | Diabetes Care2000，23，12： | 1 |
| 2 | Equity sales in belgian corporate groups: Expropriation of minority shareholders? A clinical study 显示文摘 | Buysschaert A Deloof M Jegers M | 2004 | Journal of Corporate Finance2004，，10： | 1 |
| 3 | Hyperhomocysteinemia in type 2 diabetes : relationship to macroangiopathy,nephropathy, and insulin resistance 显示文摘 | Buysschaert M Dramais AS Wallemacq PE | 2000 | Diabetes Care2000，23，12： | 1 |
| 4 | The role of alexithymia factors in glucose control of persons with type 1 diabetes:A pilot study显示文摘 | Luminet O Timary P Buysschaert M | 2006 | Diabetes Metab2006，32，5： | 1 |
| 5 | 显示文摘 | Buysschaert M Dramais AS Wallemacq PE | 2000 | Diabetes Care2000，23，12： | 1 |
| 6 | Hy- pertriglyceridemia and residual dyslipidemia in statin - treated, pa- tients with diabetes at the highest risk for cardiovascular disease and achieving very - low low - density lipoprotein - cholesterol lev- els显示文摘 | QUERTON L BUYSSCHAERT M HERMANS M P | 2012 | J Clin Lipidol2012，6，5： | 1 |
| 7 | One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice显示文摘 | Buysschaert M Preumont V Oriot PR | 2010 | Diabetes Metab2010，，36： | 1 |
| 8 | Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy and insulin resistance 显示文摘 | Buysschaert M Dramais AS Wallemacq PE | 2000 | Diabetes Care2000，23，11： | 1 |
| 9 | Hyperhomocysteinemia in 2 diabetes: relationship to macroangiopathy, nephropathy and insulin resistance显示文摘 | Buysschaert M Dramais AS Wallemacq PE | 2000 | Diabetes Care2000，23，12： | 1 |
| 10 | Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resis- tance显示文摘 | Buysschaert M Dramais AS Wallemacq PE | 2000 | Diabetes Care2000，23，12： | 1 |
| 11 | Hyperhomocysteinemia in type 2 diabetes:relationship to macroangiopathy,nephropathy,and insulin resistance显示文摘 | Buysschaert M Dramais AS Wallemacq PE | 2000 | Diabetes Care2000，23，12： | 1 |
| 12 | Hyperhomo-cysteinemia in type 2 diabetes:relationship to macroangiopathy, nephropathy, and insulin resistance显示文摘 | Buysschaert M Dramais AS Wallemacq PE | 2000 | Diabetes Care2000，23，： | 1 |
| 13 | Hyperhomocysteinemia in type 2 diabetes: relationship to maeroangiopathy, nephropathy, and in- sulin resistance 显示文摘 | Buysschaert M Dramais AS Wallemacq PE | 2000 | Diabetes Care2000，23，12： | 1 |
| 14 | Predicting factors of hypoglycaemia in elderly type 2 diabetes patients : Contributions of the GERODIAB study显示文摘 | Bordier L Buysschaert M Bauduceau B | 2015 | Diabetes Metab2015，41，4： | 1 |
| 15 | Hyperhomocysteinemia in type 2 diabetes:relationship to macroangiopathy,nephropathy,and insulin resistance显示文摘 | Buysschaert M Dramais AS Wallemacq PE | 2000 | Diabetes Care2000，23，： | 1 |
| 16 | The MTHFR CT polymor- phism confers a high risk for stroke in both homozygous and heter- ozygous T allele carriers with type 2 diabetes 显示文摘 | Hermans MP Gala JL Buysschaert M | 2006 | Diabet Med2006，23，5： | 1 |
| 17 | Definition of prediabetes 显示文摘 | Buysschaert M Bergman M | 2011 | Med Clin North Am2011，95，2： | 1 |
| 18 | Diabetes prevention: global health policy and perspectives from the ground显示文摘 | BERGMAN M BUYSSCHAERT M SCHWARZ PE | 2012 | Diabetes Manag (Lond)2012，2，30： | 1 |
| 19 | Glycemic control and weight changes in patients with type 2 diabetes intensified to three insulin regimens after therapeutic failure to exenatide显示文摘 | Buysschaert M Paris I Selvais P et a1 | 2012 | Acta Clin Belg2012，67，9： | 1 |
| 20 | Hyperhomoc-ys-teinemia in type 2 diabetes:relationship to macroangiopathy,nephropathy,and insulin resistance显示文摘 | Buysschaert M Dramais A S Wallemacq P E | | 0，，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员